Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 15 01 2019
accepted: 20 05 2019
pubmed: 28 5 2019
medline: 5 6 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

The G protein-coupled estrogen receptor (GPER) mediates an aldosterone secretagogue effect of 17β-estradiol in human HAC15 adrenocortical cells after estrogen receptor β blockade. Because GPER mediates mineralocorticoid receptor-independent aldosterone effects in other cell types, we hypothesized that aldosterone could modulate its own synthesis via GPER activation. HAC15 cells were exposed to aldosterone in the presence or absence of canrenone, a mineralocorticoid receptor antagonist, and/or of the selective GPER antagonist G36. Aldosterone synthase (CYP11B2) mRNA and protein levels changes were the study end points. Similar experiments were repeated in strips obtained ex vivo from aldosterone-producing adenoma (APA) and in GPER-silenced HAC15 cells. Aldosterone markedly increased CYP11B2 mRNA and protein expression (vs untreated samples, P < 0.001) in both models by acting via GPER, because these effects were abolished by G36 (P < 0.01) and not by canrenone. GPER-silencing (P < 0.01) abolished the aldosterone-induced increase of CYP11B2, thus proving that aldosterone acts via GPER to augment the step-limiting mitochondrial enzyme (CYP11B2) of its synthesis. Angiotensin II potentiated the GPER-mediated effect of aldosterone on CYP11B2. Coimmunoprecipitation studies provided evidence for GPER-angiotensin type-1 receptor heterodimerization. We propose that this autocrine-paracrine mechanism could enhance aldosterone biosynthesis under conditions of immediate physiological need in which the renin-angiotensin-aldosterone system is stimulated as, for example, hypovolemia. Moreover, as APA overexpresses GPER this mechanism could contribute to the aldosterone excess that occurs in primary aldosteronism in a seemingly autonomous fashion from angiotensin II.

Identifiants

pubmed: 31125081
pii: 5497102
doi: 10.1210/jc.2019-00043
doi:

Substances chimiques

Benzodioxoles 0
G36 compound 0
GPER1 protein, human 0
Mineralocorticoid Receptor Antagonists 0
Quinolines 0
Receptor, Angiotensin, Type 1 0
Receptors, Estrogen 0
Receptors, G-Protein-Coupled 0
Aldosterone 4964P6T9RB
Canrenone 78O20X9J0U
Cytochrome P-450 CYP11B2 EC 1.14.15.4
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6316-6324

Informations de copyright

Copyright © 2019 Endocrine Society.

Auteurs

Brasilina Caroccia (B)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Teresa Maria Seccia (TM)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Maria Piazza (M)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Selene Prisco (S)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Sofia Zanin (S)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Maurizio Iacobone (M)

Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

Livia Lenzini (L)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Giorgia Pallafacchina (G)

Department of Biomedical Sciences, University of Padua, Padua, Italy.
Italian National Research Council (CNR), Neuroscience Institute, Padua, Italy.

Oliver Domening (O)

Attoquant Diagnostics, Vienna, Austria.

Marko Poglitsch (M)

Attoquant Diagnostics, Vienna, Austria.

Rosario Rizzuto (R)

Department of Biomedical Sciences, University of Padua, Padua, Italy.

Gian Paolo Rossi (GP)

Specialized Center for Blood Pressure Disorders-Regione Veneto and Hypertension Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH